Latex Agglutination Test Kits Market Expansion Continues, with Forecast Valuation of $2.03 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Latex Agglutination Test Kits Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for latex agglutination test kits has seen significant growth in recent past and is expected to further expand from $1.49 billion in 2024 to $1.59 billion in 2025, showing a compound annual growth rate (CAGR) of 6.5%. This historical growth can be traced back to a surge in infectious diseases, an uptick in funding for diagnostics research and development, a heightened emphasis on infection control procedures in healare facilities, and the growing utilization of latex agglutination tests for assessing water quality.

Latex Agglutination Test Kits Market Size Forecast: What's the Projected Valuation by 2029?
In the foroming years, a significant surge is anticipated in the latex agglutination test kits market size, with it projected to reach $2.03 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.4%. The growth during this forecast period is believed to be driven by factors such as the increasing instances of infectious and autoimmune diseases, greater usage of rapid and Point of Care (POC) technologies, extended adoption of point-of-care diagnostics, improved awareness about sexually transmitted diseases, and an increase in respiratory tract infections. The forecast period is also expected to witness various major trends such as technological progress, test strip technology, antigen testing, automated procedures, and point-of-care testing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/latex-agglutination-test-kits-global-market-report

What Are the Drivers Transforming the Latex Agglutination Test Kits Market?
The surging incidence of infectious illnesses is projected to drive the expansion of the latex agglutination test kit industry in the future. These contagious diseases are ailments brought on by harmful microbes like bacteria, viruses, fungi, parasites, or prions. The soaring rate of infectious diseases can be traced to factors such as worldwide integration, resistance to antimicrobials, urban expansion, changing climate conditions, and boosted population growth. Latex agglutination examinations are habitually employed for swift detection of several infectious diseases, including bacterial and viral infections. For instance, data from the Centers for Disease Control and Prevention, a US-based national public health institution, reveals that in the United States, there were 8,331 cases of tuberculosis (TB) reported in 2022, a 5.9% surge from the 7,874 cases reported in 2021. As such, the rising occurrence of infectious diseases is anticipated to stimulate the growth of the latex agglutination test kit industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15597&type=smp

What Long-Term Trends Will Define the Future of the Latex Agglutination Test Kits Market?
Leading firms in the latex agglutination test kits market are targeting their energies on the development of diagnostic tools for foodborne diseases and environmental pollutants. They aim to provide rapid, easy-to-use latex agglutination tests to improve disease identification and secure a competitive advantage. These tests simplify pathogen recognition and provide immediate and clear identification in food and environmental specimens. For example, Gold Standard Diagnostics LLC, an American diagnostic company, unveiled Microgen rapid latex agglutination tests in March 2024. These tests, developed by Gold Standard Diagnostics, offer fast, simple, and cost-effective methods for confirming the presence of specific pathogens in food and environmental samples, like Salmonella, Legionella, or Staphylococcus aureus colonies. These tests provide a highly sensitive and particular alternative to traditional culture processes and can be completed in as little as two minutes. They also seamlessly fit into laboratory operations. These tests are so straightforward that labs can begin to use them immediately, without requiring any special training or machinery.

Which Segments in the Latex Agglutination Test Kits Market Offer the Most Profit Potential?
The latex agglutination test kits market covered in this report is segmented -

1) By Product Type: Enzyme Linked Immunosorbent Assay, Indirect Fluorescent, Hemagglutination Inhibition, Serum Neutralization
2) By Test Type: Antibody Detection, Antigen Testing
3) By Sample Type: Blood, Urine, Cerebrospinal Fluid, Other Sample Types
4) By Application: Hospitals, Diagnostic Centers, Specialty Clinics

Subsegments:
1) By Enzyme-Linked Immunosorbent Assay (Elisa) - Sandwich Elisa, Competitive Elisa, Indirect Elisa
2) By Indirect Fluorescent - Direct Immunofluorescence Assay (Difa), Indirect Immunofluorescence Assay (Ifa)
3) By Hemagglutination Inhibition - Virus-Specific Hemagglutination Inhibition Tests
4) By Serum Neutralization - Virus Neutralization Assays, Cytopathic Effect Neutralization Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15597&type=smp

Which Firms Dominate the Latex Agglutination Test Kits Market by Market Share and Revenue in 2025?
Major companies operating in the latex agglutination test kits market are Cardinal Health Inc., Thermo Fisher Scientific Inc., Becton inson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Hardy Diagnostics, Meridian Bioscience Inc., BioLegend Inc., ELITechGroup, Fujirebio, Sekisui Diagnostics LLC, R-Biopharm AG, Savyon Diagnostics Ltd., Creative Diagnostics, ZeptoMetrix Corporation, HiMedia Laboratories, DIALAB GmbH, Arlington Scientific Inc., Biotium Inc., Atlas Medical GmbH, Pro Lab Diagnostics Inc., Gold Standard Diagnostics Industrial Solutions

Which Regions Offer the Highest Growth Potential in the Latex Agglutination Test Kits Market?
North America was the largest region in the latex agglutination test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the latex agglutination test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15597

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.